CENTAURI THERAPEUTICS LIMITED

Active London

Other service activities n.e.c.

12 employees website.com
Life sciences and medical technology Other service activities n.e.c.
C

CENTAURI THERAPEUTICS LIMITED

Other service activities n.e.c.

Founded 6 Feb 2014 Active London, United Kingdom 12 employees website.com
Life sciences and medical technology Other service activities n.e.c.

Previous Company Names

ALTERMUNE LIMITED 2 Mar 2015 — 23 Dec 2015
ALTERMET LIMITED 6 Feb 2014 — 2 Mar 2015
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 21 Feb 2026 Next due 20 Feb 2027 10 months remaining
Net assets £7M £3M 2024 year on year
Total assets £7M £3M 2024 year on year
Total Liabilities £324K £134K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

First Floor 5 Fleet Place London EC4M 7RD United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CENTAURI THERAPEUTICS LIMITED (08879741), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 6 Feb 2014. Other service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£5.10M

Decreased by £4.18M (-45%)

Net Assets

£6.70M

Decreased by £3.31M (-33%)

Total Liabilities

£323.91k

Increased by £134.13k (+71%)

Turnover

N/A

Employees

12

Increased by 2 (+20%)

Debt Ratio

5%

Increased by 3 (+150%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 2Dec 2015Seed
Investor 4Feb 2022Series A
Investor 5Feb 2022Series A

Share Capital

Share Capital

Share allotments and capital structure

39 Allotments 276,480 Shares £34.58m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
8 Jan 202651,220£6.00m£117.14
10 Feb 202576,665£8.98m£117.14
10 Jul 202376,665£8.98m£117.14
26 Jan 202250,256£5.89m£117.14
26 Jan 2022952£100k£105.43

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (29)

Boehringer Ingelheim Venture Fund Gmbh
20.7%
67,343
Novo Holdings A/s
20.7%
67,343

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Lak Holdings Llp

Ceased 18 Jul 2023

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Feb 2026Confirmation StatementConfirmation statement made on 2026-02-06 with updates
30 Jan 2026ResolutionResolutions
30 Jan 2026IncorporationMemorandum Articles
15 Jan 2026CapitalAllotment of shares (GBP 783.362832) on 2026-01-08
15 Jan 2026OfficersAppointment of Henni-Karoliina Ropponen as director on 2026-01-07
21 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-02-06 with updates

30 Jan 2026 Resolution

Resolutions

30 Jan 2026 Incorporation

Memorandum Articles

15 Jan 2026 Capital

Allotment of shares (GBP 783.362832) on 2026-01-08

15 Jan 2026 Officers

Appointment of Henni-Karoliina Ropponen as director on 2026-01-07

Recent Activity

Latest Activity

Confirmation statement made on 2026-02-06 with updates

1 months ago on 21 Feb 2026

Resolutions

2 months ago on 30 Jan 2026

Memorandum Articles

2 months ago on 30 Jan 2026

Allotment of shares (GBP 783.362832) on 2026-01-08

3 months ago on 15 Jan 2026

Appointment of Henni-Karoliina Ropponen as director on 2026-01-07

3 months ago on 15 Jan 2026